DCEG researchers conduct studies and participate in consortial activities on cancers of the white blood cells, known as lymphomas. DCEG's portfolio includes studies of Burkitt lymphoma, Hodgkin lymphoma, and non-Hodgkin lymphoma and its subtypes. Selected studies and consortia include:
A hospital-based case-control study of 3,000 cases of NHL and 3,000 controls in Asia that is exploring occupational and environmental exposures, viral infections, and genetic susceptibility
A large, multidisciplinary epidemiological effort designed to evaluate environmental and host factors associated with childhood Burkitt lymphoma in sub-Saharan Africa
Studies to identify common genetic variants in relation to both NHL susceptibility and survival within the NCI-SEER NHL Study
A pooled analysis of case-control studies of non-Hodgkin lymphoma among men from Iowa, Minnesota, Kansas, and Nebraska to evaluate potential risks from pesticide and other exposures
A colloboration with several large population-based cohorts to determine whether the prevalence or level of t14;18 is associated with risk of NHL and to investigate the clonal relationship between translocation-bearing cells and subsequent tumors
A consortium designed to enhance collaboration among epidemiologists studying lymphoma, to provide a forum for the exchange of research ideas, and to create a framework for collaborating on analyses that pool data from multiple studies
An international consortial project to comprehensively evaluate the etiology of 11 non-Hodgkin lymphoma (NHL) subtypes, considering family and medical history, lifestyle and occupational risk factors, and inherited genetic susceptibility.